There is one summary for this bill. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (03/09/2009)

Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance).

Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.